Autophagy Receptors and Neurodegenerative Diseases

Trends in Cell Biology

Volumn 27, Issue 7, 2017, Pages 491-504

  Deng, Zhiqiang ^a,b,c   Purtell, Kerry ^c   Lachance, Veronik ^c   Wold, Mitchell S ^c   Chen, Shi ^a,b   Yue, Zhenyu ^c  

^a WUHAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFY PROTEIN; HUNTINGTIN; NEIGHBOR OF BRCA1; NUCLEAR DOT PROTEIN 52 KDA; OPTINEURIN; RECEPTOR; SEQUESTOSOME 1; UBIQUILIN 2; UNCLASSIFIED DRUG; CELL RECEPTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA; AUTOPHAGY; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DYSARTHRIA; DYSTONIA; FRONTOTEMPORAL DEMENTIA; GAIT DISORDER; GAZE PARALYSIS; HUMAN; HUNTINGTON CHOREA; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; UBIQUITINATION; ANIMAL; METABOLISM;

ANIMALS; AUTOPHAGY; HUMANS; NEURODEGENERATIVE DISEASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 85011296348     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2017.01.001     Document Type: Review

References (103)

1. Mizushima, N., et al. The role of Atg proteins in autophagosome formation. Annu. Rev. Cell Dev. Biol. 27 (2011), 107–132.
2. Feng, Y., et al. The machinery of macroautophagy. Cell Res. 24 (2014), 24–41.
3. Wold, M.S., et al. ULK1-mediated phosphorylation of ATG14 promotes autophagy and is impaired in Huntington's disease models. Mol. Neurodegener., 11, 2016, 76.
4. Park, J.M., et al. The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14. Autophagy 12 (2016), 547–564.
5. Russell, R.C., et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat. Cell Biol. 15 (2013), 741–750.
6. Slobodkin, M.R., Elazar, Z., The Atg8 family: multifunctional ubiquitin-like key regulators of autophagy. Essays Biochem. 55 (2013), 51–64.
7. Wild, P., et al. The LC3 interactome at a glance. J. Cell. Sci. 127 (2014), 3–9.
8. Justin Joachim, S.A.T., GABARAP activates ULK1 and traffics from the centrosome dependent on Golgi partners WAC and GOLGA2/GM130. Autophagy 12 (2016), 892–893.
9. Weidberg, H., et al. LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J. 29 (2010), 1792–1802.
10. Stolz, A., et al. Cargo recognition and trafficking in selective autophagy. Nat. Cell Biol. 16 (2014), 495–501.
11. Behrends, C., et al. Network organization of the human autophagy system. Nature 466 (2010), 68–76.
12. Tan, J.M., et al. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum. Mol. Genet. 17 (2008), 431–439.
13. Riley, B.E., et al. Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection. J. Cell Biol. 191 (2010), 537–552.
14. Khaminets, A., et al. Ubiquitin-dependent and independent signals in selective autophagy. Trends Cell Biol. 26 (2016), 6–16.
15. Cherra, S.J. III, et al. Regulation of the autophagy protein LC3 by phosphorylation. J. Cell Biol. 190 (2010), 533–539.
16. Lim, J., et al. Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates. PLoS Genet., 11, 2015, e1004987.
17. Ohtsuka, S., et al. SQSTM1/p62/A170 regulates the severity of Legionella pneumophila pneumonia by modulating inflammasome activity. Eur. J. Immunol. 44 (2014), 1084–1092.
18. Kang, C., et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science, 349, 2015, aaa5612.
19. Linares, J.F., et al. Amino acid activation of mTORC1 by a PB1-domain-driven kinase complex cascade. Cell Rep. 12 (2015), 1339–1352.
20. Matsumoto, G., et al. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol. Cell 44 (2011), 279–289.
21. Pilli, M., et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 37 (2012), 223–234.
22. Ichimura, Y., et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell 51 (2013), 618–631.
23. Pan, J.A., et al. TRIM21 ubiquitylates SQSTM1/p62 and suppresses protein sequestration to regulate redox homeostasis. Mol Cell 61 (2016), 720–733.
24. Ito, Y., et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353 (2016), 603–608.
25. Wild, P., et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333 (2011), 228–233.
26. Richter, B., et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 4039–4044.
27. Archambault, V., Glover, D.M., Polo-like kinases: conservation and divergence in their functions and regulation. Nat. Rev. Mol. Cell Biol. 10 (2009), 265–275.
28. Liu, Z., et al. Ubiquitylation of autophagy receptor optineurin by HACE1 activates selective autophagy for tumor suppression. Cancer Cell 26 (2014), 106–120.
29. Nicot, A.S., et al. Phosphorylation of NBR1 by GSK3 modulates protein aggregation. Autophagy 10 (2014), 1036–1053.
30. Maruyama, H., Kawakami, H., Optineurin and amyotrophic lateral sclerosis. Geriatr. Gerontol. Int. 13 (2013), 528–532.
31. Kachaner, D., et al. Toward an integrative view of optineurin functions. Cell Cycle 11 (2012), 2808–2818.
32. Rea, S.L., et al. SQSTM1 mutations – bridging Paget disease of bone and ALS/FTLD. Exp.Cell Res. 325 (2014), 27–37.
33. van der Zee, J., et al. Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol. 128 (2014), 397–410.
34. Deng, H.X., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477 (2011), 211–215.
35. Dillen, L., et al. Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients. Neurobiol. Aging, 34, 2013 1711 e1711–1715.
36. Kamada, M., et al. Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation. Neuropathology 34 (2014), 64–70.
37. Li, C., et al. Optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in China. Amyotroph. Lateral Scler. Frontotemporal. Degener. 16 (2015), 485–489.
38. Pottier, C., et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 130 (2015), 77–92.
39. Cirulli, E.T., et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347 (2015), 1436–1441.
40. Freischmidt, A., et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 18 (2015), 631–636.
41. Shen, W.C., et al. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy 11 (2015), 685–700.
42. Korac, J., et al. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J. Cell Sci. 126 (2013), 580–592.
43. Wong, Y.C., Holzbaur, E.L., Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E4439–4448.
44. Rea, S.L., et al. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone. Endocr. Rev. 34 (2013), 501–524.
45. Mizuno, Y., et al. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 249 (2006), 13–18.
46. Arai, T., et al. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci. Lett. 342 (2003), 41–44.
47. Hiji, M., et al. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin. Acta Neuropathol. 116 (2008), 183–191.
48. Lim, J., Yue, Z., Neuronal aggregates: formation, clearance, and spreading. Dev. Cell 32 (2015), 491–501.
49. Lattante, S., et al. Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD. Hum. Mol. Genet. 24 (2015), 1682–1690.
50. Goode, A., et al. Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD. Autophagy 12 (2016), 1094–1104.
51. Goode, A., et al. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling. Mol. Cell. Neurosci. 76 (2016), 52–58.
52. Brady, O.A., et al. Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1. J. Neurochem. 116 (2011), 248–259.
53. Hadano, S., et al. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. Hum. Mol. Genet. 25 (2016), 3321–3340.
54. N'Diaye, E.N., et al. PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep. 10 (2009), 173–179.
55. Rothenberg, C., et al. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum. Mol. Genet. 19 (2010), 3219–3232.
56. Wu, Q., et al. Pathogenic Ubqln2 gains toxic properties to induce neuron death. Acta Neuropathol. 129 (2015), 417–428.
57. Osaka, M., et al. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2. Biochem. Biophys. Res. Commun. 472 (2016), 324–331.
58. Hjerpe, R., et al. UBQLN2 Mediates autophagy-independent protein aggregate clearance by the proteasome. Cell 166 (2016), 935–949.
59. van Duijn, E.E.A., Psychopathology in verified Huntington's disease gene carriers. J. Neuropsychiatry Clin. Neurosci. 19 (2007), 441–448.
60. No authors listed, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington“s disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72 (1993), 971–983.
61. DiFiglia, M.E.A., Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997), 1990–1993.
62. Maat-Schieman, M.L.E.A., Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. J. Neuropathol. Exp. Neurol. 58 (1999), 129–137.
63. Atwal, R.S., et al. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum. Mol. Genet. 16 (2007), 2600–2615.
64. Rui, Y.N., et al. Huntingtin functions as a scaffold for selective macroautophagy. Nat. Cell Biol. 17 (2015), 262–275.
65. Thompson, L.M., et al. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell Biol. 187 (2009), 1083–1099.
66. Anne, S.L., et al. Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. J. Neurosci. 27 (2007), 7318–7328.
67. Humbert, S., et al. The IGF-1 Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev. Cell 2 (2002), 831–837.
68. Bjorkoy, G., et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171 (2005), 603–614.
69. Kurosawa, M., et al. Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington's model mice. Hum. Mol. Genet. 24 (2015), 1092–1105.
70. Simonsen, A.E.A., Alfy, a novel FYVE-domain-containing protein associated with protein granules and autophagic membranes. J. Cell. Sci. 117 (2004), 4239–4251.
71. Clausen, T.H., et al. p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy. Autophagy 6 (2014), 330–344.
72. Filimonenko, M., et al. The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol. Cell 38 (2010), 265–279.
73. Yamamoto, A., Simonsen, A., Alfy-dependent elimination of aggregated proteins by macroautophagy: can there be too much of a good thing?. Autophagy 7 (2011), 346–350.
74. Lystad, A.H., et al. Structural determinants in GABARAP required for the selective binding and recruitment of ALFY to LC3B-positive structures. EMBO Rep. 15 (2014), 557–565.
75. Hattula, K., Peranen, J., FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr. Biol. 10 (2000), 1603–1606.
76. del Toro, D., et al. Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. Mol. Biol. Cell 20 (2009), 1478–1492.
77. Schwab, C., et al. Optineurin in Huntington's disease intranuclear inclusions. Neurosci. Lett. 506 (2012), 149–154.
78. Lu, K., et al. Autophagic clearance of polyQ proteins mediated by ubiquitin-Atg8 adaptors of the conserved CUET protein family. Cell 158 (2014), 549–563.
79. Osawa, T., et al. Optineurin in neurodegenerative diseases. Neuropathology 31 (2011), 569–574.
80. Odagiri, S., et al. Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in alpha-synucleinopathy. Acta Neuropathol. 124 (2012), 173–186.
81. Tanji, K., et al. p62 Deficiency enhances alpha-synuclein pathology in mice. Brain Pathol. 25 (2015), 552–564.
82. Narendra, D., et al. p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6 (2014), 1090–1106.
83. Okatsu, K., et al. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes Cells 15 (2010), 887–900.
84. Lazarou, M., et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524 (2015), 309–314.
85. Soubannier, V., et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr. Biol. 22 (2012), 135–141.
86. McLelland, G.L., et al. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J. 33 (2014), 282–295.
87. Nixon, R.A., Yang, D.S., Autophagy failure in Alzheimer's disease – locating the primary defect. Neurobiol. Dis. 43 (2011), 38–45.
88. Nixon, R.A., et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 64 (2005), 113–122.
89. Salminen, A., et al. Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease. Prog. Neurobiol. 96 (2012), 87–95.
90. Cuyvers, E., et al. Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study. Neurobiol. Aging, 36, 2015 2005 e2015–2022.
91. Tanji, K., et al. Phosphorylation of serine 349 of p62 in Alzheimer's disease brain. Acta Neuropathol. Commun., 2, 2014, 50.
92. Ramesh Babu, J., et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J. Neurochem. 106 (2008), 107–120.
93. Caccamo, A., et al. p62 improves AD-like pathology by increasing autophagy. Mol. Psychiatry, 2016, 10.1038/mp.2016.139.
94. Jo, C., et al. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat. Commun., 5, 2014, 3496.
95. Haack, T.B., et al. Absence of the autophagy adaptor SQSTM1/p62 causes childhood-onset neurodegeneration with ataxia, dystonia, and gaze palsy. Am. J. Hum. Genet. 99 (2016), 735–743.
96. Rue, L., et al. Brain region- and age-dependent dysregulation of p62 and NBR1 in a mouse model of Huntington's disease. Neurobiol. Dis. 52 (2013), 219–228.
97. Kachaner, D., et al. Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression. Mol. Cell 45 (2012), 553–566.
98. Maruyama, H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465 (2010), 223–226.
99. Zhang, K.Y., et al. Ubiquilin 2: a component of the ubiquitin-proteasome system with an emerging role in neurodegeneration. Int. J. Biochem. Cell Biol. 50 (2014), 123–126.
100. Han, H., et al. Autophagy-linked FYVE protein (Alfy) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). In Vitro Cell. Dev. Biol. Anim. 51 (2015), 249–263.
101. Kim, S., et al. NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model. Biochem. Biophys. Res. Commun. 454 (2014), 196–201.
102. Lin, L., et al. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin. Brain Res. 1643 (2016), 103–112.
103. Zucchelli, S., et al. Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation. J. Biol. Chem. 286 (2011), 25108–25117.